Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06883266 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
A NA study of Parkinsons Disease (PD), sponsored by Sanford Health.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06883266: Recruiting NA study of Parkinsons Disease (PD), sponsored by Sanford Health.
NCT06883266 is a NA study of Parkinsons Disease (PD) that is actively recruiting participants, run by Sanford Health. The registered enrollment target is 64 participants, below the 116-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06883266, a NA study of Parkinsons Disease (PD), is actively recruiting participants, sponsored by Sanford Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left primary motor cortex (M1) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.
Primary Outcome
We will use the KinesiaOne measure the finger tapping and foot tapping for 15 seconds. It will repeat 3 times at 1 minute intervals. KinesiaOne is a light-weight device that can be attached to the Index finger or ankle. It measures the acceleration and deceleration of the finger or foot. The measurement is transmitted to the KinesiaOne tablet that allows further data processing.
Conditions Studied
Interventions
- DEVICE transcranial direct current stimulation (tDCS)
- DEVICE Sham (No Treatment)
Study Locations (1)
North Dakota
- Sanford Brain and Spine Center - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2026-12-11 |
| Phase | NA |
What NCT06883266 shows while recruiting
NCT06883266 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 116-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Parkinsons Disease (PD) appearing as the primary indexed condition, and to 2 interventions - of which transcranial direct current stimulation (tDCS) is the first listed.
NCT06883266 reports a single indexed study location in North Dakota.
Frequently Asked Questions
What is clinical trial NCT06883266 about?
NCT06883266 is a clinical study titled "Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD". The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left primary motor cortex (M1) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.
What is the current status of trial NCT06883266?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2024-11-11. Estimated completion is 2026-12-11.
What conditions does trial NCT06883266 study?
This clinical trial studies the following conditions: Parkinsons Disease (PD).
What interventions are being tested in trial NCT06883266?
The interventions under investigation include: transcranial direct current stimulation (tDCS) (DEVICE), Sham (No Treatment) (DEVICE).
Who is sponsoring clinical trial NCT06883266?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06883266 being conducted?
This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinsons Disease (PD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06883266's enrollment target sits among peer trials
64 12th of 19 higher than 8 of 19 other Parkinsons Disease (PD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinsons Disease (PD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
RECRUITING · NA
-
Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
RECRUITING · NA
-
Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease
RECRUITING · NA
-
Electrophysiology-based DBS Programming for PD
RECRUITING · NA
-
A Study of NE3107 in Early Parkinson's
RECRUITING · Phase 2
-
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI